Trademarkia Logo

Canada

C$
Trademark Search in Canada
XIMENCY & DCV TRIO PLAY DESIGN
XIMENCY & DCV TRIO PLAY DESIGN
REGISTERED

on 4 Oct 2019

Last Applicant/ Owned by

BRISTOL-MYERS SQUIBB HOLDINGS IRELAND UNLIMITED COMPANY

Hinterbergstrasse 166312 Steinhausen

CH

Serial Number

1756552 filed on 25th Nov 2015

Registration Number

TMA1057617 registered on 4th Oct 2019

Registration expiry Date

4th Oct 2029

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

XIMENCY & DCV TRIO PLAY DESIGN

Trademark usage description

pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer Read More

Vienna Information


9 . 1 . 10

Ribbons, bowsRubans, noeuds

26 . 4 . 3

Rhombs or squares standing on one of the corners thereofLosanges ou carrés sur pointe

26 . 3 . 1

One triangleUn triangle

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

29 . 1 . 3

GreenVert

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

29 . 1 . 4

BlueBleu

Classification Information


Class [005]
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, respiratory diseases, auto-immune diseases, solid organ transplant rejection, hepatitis; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents


Classification kind code

10

Mark Details


Serial Number

1756552

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 15
on 14th Mar 2018
Correspondence Created
Submitted for opposition 80
on 2th May 2017
Change of Title Registered
Submitted for opposition 12
on 29th Mar 2017
Extension of Time
Submitted for opposition 22
on 21st Sept 2016
Search Recorded
Submitted for opposition 20
on 21st Sept 2016
Examiner's First Report
Submitted for opposition 67
on 25th Feb 2016
Agent Name Changed
Submitted for opposition 68
on 25th Feb 2016
Rep for Service Name Changed
Submitted for opposition 31
on 1st Dec 2015
Formalized
Submitted for opposition 1
on 26th Nov 2015
Created
Submitted for opposition 30
on 25th Nov 2015
Filed